Insider · CIK 0001423898
Rebecca Taub
director
Files at MDGL (MADRIGAL PHARMACEUTICALS, INC.). First filing Jul 18, 2025, latest Dec 12, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $37M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MDGL: MADRIGAL PHARMACEUTICALS, INC.
MDGLOct 9, 2026 · close 471.75
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | MADRIGAL PHARMACEUTICALS, INC. | $10M 18,650 shares | -4% | +106% from low-8% from high | |
| 25Weak | MADRIGAL PHARMACEUTICALS, INC. | $17M 46,463 shares | -10% | +73% from low-2% from high | |
| 3Weak | MADRIGAL PHARMACEUTICALS, INC. | $350k 1,000 shares | -0% | +65% from low-6% from high | |
| 13Weak | MADRIGAL PHARMACEUTICALS, INC. | $10M 29,101 shares | -6% | +70% from low-3% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +18,650 | $15.80 | $295k | 479,694 | Dec 12, 2025 |
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -491 | $547.76 | $269k | 479,203 | Dec 12, 2025 |
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -369 | $548.56 | $202k | 478,834 | Dec 12, 2025 |
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -486 | $550.07 | $267k | 478,348 | Dec 12, 2025 |
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4,723 | $550.99 | $2.6M | 473,625 | Dec 12, 2025 |
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4,410 | $551.85 | $2.4M | 469,215 | Dec 12, 2025 |
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -3,857 | $552.81 | $2.1M | 465,358 | Dec 12, 2025 |
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -3,087 | $553.88 | $1.7M | 462,271 | Dec 12, 2025 |
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,027 | $554.84 | $570k | 461,244 | Dec 12, 2025 |
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -200 | $555.39 | $111k | 461,044 | Dec 12, 2025 |
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | GGift Common Stock10b5-1 | -5,455 | $0.00 | $0 | 455,589 | Dec 12, 2025 |
| Dec 10, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -18,650 | $0.00 | $0 | 18,650 | Dec 12, 2025 |
| Aug 11, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +3,200 | $9.45 | $30k | 464,244 | Aug 13, 2025 |
| Aug 11, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2,980 | $350.18 | $1.0M | 461,264 | Aug 13, 2025 |
| Aug 11, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -220 | $351.02 | $77k | 461,044 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +43,263 | $9.45 | $409k | 504,307 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -3,580 | $350.87 | $1.3M | 500,727 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2,870 | $351.60 | $1.0M | 497,857 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,175 | $352.45 | $414k | 496,682 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4,587 | $354.04 | $1.6M | 492,095 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6,479 | $354.97 | $2.3M | 485,616 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -5,752 | $355.95 | $2.0M | 479,864 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4,864 | $356.88 | $1.7M | 475,000 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6,715 | $357.85 | $2.4M | 468,285 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6,541 | $358.81 | $2.3M | 461,744 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -700 | $359.71 | $252k | 461,044 | Aug 13, 2025 |
| Aug 11, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,200 | $0.00 | $0 | 43,263 | Aug 13, 2025 |
| Aug 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -43,263 | $0.00 | $0 | 0 | Aug 13, 2025 |
| Jul 18, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +1,000 | $9.45 | $9,450 | 462,044 | Jul 22, 2025 |
| Jul 18, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,000 | $350.01 | $350k | 461,044 | Jul 22, 2025 |
| Jul 18, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 46,463 | Jul 22, 2025 |
| Jul 16, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +26,444 | $9.45 | $250k | 487,488 | Jul 18, 2025 |
| Jul 16, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6,000 | $350.19 | $2.1M | 481,488 | Jul 18, 2025 |
| Jul 16, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,897 | $351.37 | $667k | 479,591 | Jul 18, 2025 |
| Jul 16, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2,357 | $352.64 | $831k | 477,234 | Jul 18, 2025 |
| Jul 16, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2,569 | $353.82 | $909k | 474,665 | Jul 18, 2025 |
| Jul 16, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -5,800 | $354.61 | $2.1M | 468,865 | Jul 18, 2025 |
| Jul 16, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6,441 | $355.61 | $2.3M | 462,424 | Jul 18, 2025 |
| Jul 16, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,380 | $356.52 | $492k | 461,044 | Jul 18, 2025 |
| Jul 17, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +2,657 | $9.45 | $25k | 463,701 | Jul 18, 2025 |
| Jul 17, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2,057 | $350.09 | $720k | 461,644 | Jul 18, 2025 |
| Jul 17, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -600 | $351.50 | $211k | 461,044 | Jul 18, 2025 |
| Jul 16, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -26,444 | $0.00 | $0 | 50,120 | Jul 18, 2025 |
| Jul 17, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,657 | $0.00 | $0 | 47,463 | Jul 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.